Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 26, 2006

Viropro Will Use NRC-BRI’s Protein Expression Systems

  • Viropro will use the National Research Council-Biotechnology Research Institute’s (NRC-BRI) inducible expression systems, under an agreement with them.

    These expression systems are integrated into CHO cells, which are used by Viropro for its transfer of technology. They are designed to control and maximize the expression of proteins thus allowing high production yields, as well as time and cost savings, according to the company.

    Viropro has also obtained a worldwide, exclusive licence for the production of the recombinant human interferon-β.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »